| Literature DB >> 34539968 |
Guoze Wang1,2, Peng Luo1,2, Shuai Zhang1,3, Qun Huang1,2, Shuling Zhang1,2, Qibing Zeng1, Jingxin Mao1,4.
Abstract
Objective. Depression is a common mental disease with long course and high recurrence rate. Previous studies showed that Puerariae Radix and its extracts have powerful antidepressant effects in recent years. The study proposed an integrated strategy, combining network pharmacology and molecular pharmacology experiment to investigate the mechanisms of the antidepressant active ingredients from Puerariae Radix. Methods. TCMSP database, GeneCards database, Venny 2.1, UniProt database, STRING database, Cytoscape 3.7.2, and Metascape database were used to screen the active chemical components, antidepressant-related genes, and core targets, convert the abbreviated gene names in batch, search and predict the interaction between proteins, and construct the PPI network of Puerariae Radix. KEGG pathway and GO biological process enrichment and biological annotation were used to select antidepressant core gene targets. The MTT method was used to detect the effect of puerarin on the damage of PC12 cells induced by corticosterone. The DCFH-DA probe and ROS assay kit were utilized to detect the production of ROS in PC12 cells. PI/Annexin V was used to detect the apoptotic rate of puerarin on PC12 cells. Western blotting was used to verify the regulation of puerarin on the key targets of AKT1, FOS, CASP3, STAT3, and TNF-α in PC12 cells. Results and Conclusion. Eight main active components, 64 potential antidepressant gene targets, and 15 core antidepressant gene targets were obtained. 35 signaling pathways and 52 biological processes related to antidepressant effect of Puerariae Radix were identified. Puerarin was the active ingredient derived from Puerariae Radix which exhibited the antidepression effect by improving the viability of cell, reducing cell apoptosis, regulating ROS production, increasing protein expressions of AKT1 and FOS, and reducing protein expressions of CASP3, STAT3, and TNF-α. The study revealed the pharmacodynamic material basis and possible antidepressant mechanism of Puerariae Radix and provided new theoretical basis and ideas for antidepressant research.Entities:
Mesh:
Substances:
Year: 2021 PMID: 34539968 PMCID: PMC8445728 DOI: 10.1155/2021/2230195
Source DB: PubMed Journal: Oxid Med Cell Longev ISSN: 1942-0994 Impact factor: 6.543
Easily absorbed active components and their basic parameters in Puerariae Radix.
| ID | Ingredient | MW | AlogP | Hdon | Hacc | OB (%) | DL |
|---|---|---|---|---|---|---|---|
| MOL000392 | Formononetin | 268.28 | 2.58 | 1 | 4 | 69.67 | 0.21 |
| MOL000357 | Sitogluside | 576.95 | 6.34 | 4 | 6 | 20.63 | 0.62 |
| MOL000358 | Beta-sitosterol | 414.79 | 8.08 | 1 | 1 | 36.91 | 0.75 |
| MOL002347 | (R)-allantoin | 158.14 | -1.76 | 5 | 7 | 96.9 | 0.03 |
| MOL002959 | 3′-Methoxydaidzein | 284.28 | 2.32 | 2 | 5 | 48.57 | 0.24 |
| MOL003629 | Daidzein-4,7-diglucoside | 578.57 | -1.48 | 8 | 14 | 47.27 | 0.67 |
| MOL012297 | Puerarin | 416.41 | -0.06 | 6 | 9 | 24.03 | 0.69 |
| MOL004631 | 7,8,4′-Trihydroxyisoflavone | 270.25 | 2.07 | 3 | 5 | 20.67 | 0.22 |
Figure 1Active components of Puerariae Radix-prediction target network diagram and distribution map of degree value and betweenness centrality.
Figure 2Venn diagram of common targets.
Antidepressant targets of active components from Puerariae Radix.
| Gene | Target name |
|---|---|
| NOS2 | Nitric oxide synthase 2 |
| CHRM1 | Cholinergic receptor muscarinic 1 |
| ESR1 | Estrogen receptor 1 |
| AR | Androgen receptor |
| PTGS2 | Prostaglandin-endoperoxide synthase 2 |
| PDE3A | Phosphodiesterase 3A |
| ADRA1D | Adrenoceptor alpha 1D |
| SLC6A3 | Solute carrier family 6 member 3 |
| ADRB2 | Adrenoceptor beta 2 |
| SLC6A4 | Solute carrier family 6 member 4 |
| ESR2 | Estrogen receptor 2 |
| DPP4 | Dipeptidyl peptidase 4 |
| MAPK14 | Mitogen-activated protein kinase 14 |
| GSK3B | Glycogen synthase kinase 3 beta |
| HSP90AA1 | Heat shock protein 90 alpha family class A member 1 |
| MAOB | Monoamine oxidase B |
| ACHE | Acetylcholinesterase (Cartwright blood group) |
| JUN | Jun protooncogene, AP-1 transcription factor subunit |
| IL4 | Interleukin 4 |
| SIRT1 | Sirtuin 1 |
| CHRM3 | Cholinergic receptor muscarinic 3 |
| KCNH2 | Potassium voltage-gated channel subfamily H member 2 |
| SCN5A | Sodium voltage-gated channel alpha subunit 5 |
| HTR3A | 5-Hydroxytryptamine receptor 3A |
| ADRA1B | Adrenoceptor alpha 1B |
| NCOA2 | Nuclear receptor coactivator 2 |
| DRD1 | Dopamine receptor D1 |
| CHRM4 | Cholinergic receptor muscarinic 4 |
| HTR2A | 5-Hydroxytryptamine receptor 2A |
| CHRM2 | Cholinergic receptor muscarinic 2 |
| CHRNA2 | Cholinergic receptor nicotinic alpha 2 subunit |
| OPRM1 | Opioid receptor Mu 1 |
| GABRA1 | Gamma-aminobutyric acid type A receptor subunit alpha1 |
| BCL2 | BCL2 apoptosis regulator |
| BAX | BCL2-associated X, apoptosis regulator |
| CASP9 | Caspase-9 |
| CASP3 | Caspase-3 |
| TGFB1 | Transforming growth factor beta 1 |
| PON1 | Paraoxonase 1 |
| MAP2 | Microtubule-associated protein 2 |
| GRIA2 | Glutamate ionotropic receptor AMPA type subunit 2 |
| NCOA1 | Nuclear receptor coactivator 1 |
| STAT3 | Signal transducer and activator of transcription 3 |
| AKT1 | AKT serine/threonine kinase 1 |
| VEGFA | Vascular endothelial growth factor A |
| FOS | Fos protooncogene, AP-1 transcription factor subunit |
| CD40LG | CD40 ligand |
| NFKBIA | NFKB inhibitor alpha |
| SOD1 | Superoxide dismutase 1 |
| HIF1A | Hypoxia-inducible factor 1 subunit alpha |
| FAS | Fas cell surface death receptor |
| VCAM1 | Vascular cell adhesion molecule 1 |
| PLAT | Plasminogen activator, tissue type |
| CYP19A1 | Cytochrome P450 family 19 subfamily A member 1 |
| GSTP1 | Glutathione S-transferase Pi 1 |
| SELP | Selectin P |
| AGTR1 | Angiotensin II receptor type 1 |
| AKR1B1 | Aldo-keto reductase family 1 member B |
| IFNB1 | Interferon beta 1 |
| GPT | Glutamic--pyruvic transaminase |
| PGP | Phosphoglycolate phosphatase |
| IFNA1 | Interferon alpha 1 |
| LEPR | Leptin receptor |
| F2R | Coagulation factor II thrombin receptor |
Figure 3Active components of Puerariae Radix-antidepressant target network and distribution map of degree value and betweenness centrality.
Figure 4PPI network of active compounds-antidepressant target protein of Puerariae Radix.
Core antidepressant targets of Puerariae Radix and their topological characteristics.
| Core gene | Target name | Degree | Betweenness centrality |
|---|---|---|---|
| AKT1 | AKT serine/threonine kinase 1 | 33 | 0.1808849 |
| FOS | Fos protooncogene, AP-1 transcription factor subunit | 28 | 0.12839175 |
| CASP3 | Caspase-3 | 27 | 0.05017522 |
| JUN | Jun protooncogene, AP-1 transcription factor subunit | 25 | 0.04969618 |
| VEGFA | Vascular endothelial growth factor A | 25 | 0.0346735 |
| STAT3 | Signal transducer and activator of transcription 3 | 24 | 0.02416106 |
| PTGS2 | Prostaglandin-endoperoxide synthase 2 | 22 | 0.01342578 |
| MAPK14 | Mitogen-activated protein kinase 14 | 20 | 0.00748504 |
| ESR1 | Estrogen receptor 1 | 19 | 0.00626354 |
| SIRT1 | Sirtuin 1 | 19 | 0.01170971 |
| HSP90AA1 | Heat shock protein 90 alpha family class A member | 18 | 0.04733413 |
| ACHE | Acetylcholinesterase (cartwright blood group) | 18 | 0.07253423 |
| SOD1 | Superoxide dismutase 1, soluble | 17 | 0.02514393 |
| HIF1A | Hypoxia-inducible factor 1 alpha subunit | 17 | 0.00556528 |
| AR | Androgen receptor | 16 | 0.0133448 |
Figure 5Enrichment analysis diagrams of KEGG pathway and GO biological process.
Figure 6Effect of corticosterone and puerarin, respectively, on the activity of PC12 cells.
Figure 7Effect of puerarin on corticosterone-induced ROS generation in PC12 cells.
Figure 8Effect of puerarin on apoptosis of PC12 cells induced by corticosterone.
Figure 9Effect of puerarin on protein expression in depression-related pathway.